Unveiling X-linked Alport Syndrome: Genetic Testing in FSGS

Introduction: FSGS is often considered in the evaluation of patients with CKD and proteinuria. As a histopathologic pattern of injury with various causes, investigating the underlying etiology of podocyte injury is crucial, given its potential therapeutic implications. Recent advances in genetic testing have revealed pathogenic variants of Alport’s syndrome (AS) in patients presenting with biopsy findings of FSGS. Here, we present a patient with biopsy proven FSGS subsequently found to have X-linked AS. Case Description: An 18 y/o man with CKD was evaluated for HTN at age 7, at which time he had a normal creatinine (Cr) and microscopic hematuria without proteinuria. He was started on an ACE-i. At age 16, he developed proteinuria, with a biopsy showing FSGS and acute interstitial nephritis (AIN). There was insufficient sample for EM analysis. A course of steroids was prescribed for the AIN. Now, he has developed significant HTN, rising Cr, and worsening proteinuria. He had no history of vision or hearing issues. Further evaluation of his family revealed siblings with microscopic hematuria. Genetic testing was done now 11 yrs after the biopsy and showed a mutation within the COL4A5 gene, consistent with X-linked AS. Discussion: FSGS of genetic origin can appear at different ages and exhibit varying degrees of proteinuria and foot process effacement. Recent advancements have shed light on the role of COL4A3-5 mutations in the development of FSGS amongst patients diagnosed with primary FSGS or steroid-resistant nephrotic syndrome. AS diagnosis has significant implications not only for the patient but also their family members who are at risk for the spectrum of systemic manifestations of the condition. Early diagnosis also allows for patients to be enrolled in clinical trials to help our therapeutic options. This case underscores the importance of accurately classifying patients with FSGS and highlights the pivotal role of genetic testing in managing CKD.PAS stain showing segmental scar (arrow)

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.2024zm730753
Primary Topic
Cell Adhesion Molecules Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unveiling X-linked Alport Syndrome: Genetic Testing in FSGS

Pravir V. Baxi, Agrawal Niraj, Steven Thomas Heidt
Journal of the American Society of Nephrology
Cell Adhesion Molecules Research
article

Unveiling X-linked Alport Syndrome: Genetic Testing in FSGS

Pravir V. Baxi, Agrawal Niraj, Steven Thomas Heidt
article en

Abstract

Introduction: FSGS is often considered in the evaluation of patients with CKD and proteinuria. As a histopathologic pattern of injury with various causes, investigating the underlying etiology of podocyte injury is crucial, given its potential therapeutic implications. Recent advances in genetic testing have revealed pathogenic variants of Alport’s syndrome (AS) in patients presenting with biopsy findings of FSGS. Here, we present a patient with biopsy proven FSGS subsequently found to have X-linked AS. Case Description: An 18 y/o man with CKD was evaluated for HTN at age 7, at which time he had a normal creatinine (Cr) and microscopic hematuria without proteinuria. He was started on an ACE-i. At age 16, he developed proteinuria, with a biopsy showing FSGS and acute interstitial nephritis (AIN). There was insufficient sample for EM analysis. A course of steroids was prescribed for the AIN. Now, he has developed significant HTN, rising Cr, and worsening proteinuria. He had no history of vision or hearing issues. Further evaluation of his family revealed siblings with microscopic hematuria. Genetic testing was done now 11 yrs after the biopsy and showed a mutation within the COL4A5 gene, consistent with X-linked AS. Discussion: FSGS of genetic origin can appear at different ages and exhibit varying degrees of proteinuria and foot process effacement. Recent advancements have shed light on the role of COL4A3-5 mutations in the development of FSGS amongst patients diagnosed with primary FSGS or steroid-resistant nephrotic syndrome. AS diagnosis has significant implications not only for the patient but also their family members who are at risk for the spectrum of systemic manifestations of the condition. Early diagnosis also allows for patients to be enrolled in clinical trials to help our therapeutic options. This case underscores the importance of accurately classifying patients with FSGS and highlights the pivotal role of genetic testing in managing CKD.PAS stain showing segmental scar (arrow)

Journal of the American Society of NephrologyVol. 35(10S)
Rush University Medical Center (US)
Openalex Percentile: Top 72%
Cell Adhesion Molecules Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Unveiling X-linked Alport Syndrome: Genetic Testing in FSGS — Pravir V. Baxi, Agrawal Niraj, et al. · Journal of the American Society of Nephrology (2024) | TGRS Research Map | TGRS